Back to top Open menu arrow
Purchase PDF

Save Save

Cite Cite

Reprints
Sections
METHODS RESULTS DISCUSSION CONCLUSION Clinical Points
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Meta-Analysis March 27, 2023

The Neuropsychological Mechanisms of Treatment of Bipolar Disorder and Borderline Personality Disorder: Activation Likelihood Estimation Meta-Analysis of Brain Imaging Research

; ; ;

J Clin Psychiatry 2023;84(3):22r14463

ABSTRACT

Objective: To explore the alteration of brain regions after treatments for bipolar disorder (BD) and borderline personality disorder (BPD) in order to discover the underlying neural mechanisms of therapies.

Data Sources: An electronic search of the PubMed, Embase, Cochrane Library, and Web of Science databases from inception until June 2021 was conducted.

Study Selection: Articles reporting the results of changes in brain activation after treatment, to assess the effects of therapy relative to a before-treatment condition, were included. A total of 1,592 records were retrieved, with 34 studies ultimately included.

Data Extraction: Activation coordinates were extracted from each study. We used activation likelihood estimation meta-analysis to evaluate the similarities and differences in the activation of different brain regions in patients with BD and BPD after treatment with psychotherapy and drug therapy.

Results: Most brain regions with abnormal activation were improved after treatments for BD and BPD. The brain activity changes produced by psychotherapy were mostly in the frontal areas, while drug therapy primarily impacted the limbic areas. In BD, treatments were associated with activation alterations in the inferior frontal gyrus, superior temporal gyrus, and cingulate gyrus, while in BPD, treatments were associated with activation alterations in the supramarginal gyrus, middle frontal gyrus, and parahippocampal gyrus.

Conclusions: These results suggest that drug therapy might have a bottom-up effect, while psychotherapy might have a top-down effect. This study may contribute to the clinical prediction of treatment efficacy in BD and BPD and to the identification of more accurate neuroimaging biomarkers for treatment of the two disorders.

Continue Reading...

Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Buy PDF for $40

Please sign in or purchase this PDF for $40.

  1. Benazzi F. Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs. 2007;21(9):727–740. PubMed CrossRef
  2. Teh WL, Abdin E, Vaingankar J, et al. Prevalence and correlates of bipolar spectrum disorders in Singapore: results from the 2016 Singapore Mental Health Study (SMHS 2016). J Affect Disord. 2020;274:339–346. PubMed CrossRef
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Publishing; 2013.
  4. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533–545. PubMed CrossRef
  5. Chanen A, Sharp C, Hoffman P; Global Alliance for Prevention and Early Intervention for Borderline Personality Disorder. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry. 2017;16(2):215–216. PubMed CrossRef
  6. Ghaemi SN, Barroilhet S. Confusing borderline personality with severe bipolar illness. Acta Psychiatr Scand. 2015;132(4):281–282. PubMed CrossRef
  7. Agius M, Lee J, Gardner J, et al. Bipolar II disorder and borderline personality disorder - co-morbidity or spectrum? Psychiatr Danub. 2012;24(suppl 1):S197–S201. PubMed
  8. Vieta E, Suppes T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 2008;10(1 Pt 2):163–178. PubMed CrossRef
  9. Fornaro M, Orsolini L, Marini S, et al. The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. J Affect Disord. 2016;195:105–118. PubMed CrossRef
  10. Henry C, Mitropoulou V, New AS, et al. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res. 2001;35(6):307–312. PubMed CrossRef
  11. Zimmerman M, Morgan TA. Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder. Curr Psychiatry Rep. 2013;15(12):422. PubMed CrossRef
  12. Paris J, Black DW. Borderline personality disorder and bipolar disorder: what is the difference and why does it matter? J Nerv Ment Dis. 2015;203(1):3–7. PubMed CrossRef
  13. Oud M, Mayo-Wilson E, Braidwood R, et al. Psychological interventions for adults with bipolar disorder: systematic review and meta-analysis. Br J Psychiatry. 2016;208(3):213–222. PubMed CrossRef
  14. Baldessarini RJ, Tondo L, Vázquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry. 2019;24(2):198–217. PubMed CrossRef
  15. Chiang KJ, Tsai JC, Liu D, et al. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials. PLoS One. 2017;12(5):e0176849. PubMed CrossRef
  16. Szentagotai A, David D. The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis. J Clin Psychiatry. 2010;71(1):66–72. PubMed CrossRef
  17. Bailly D. Pharmacological treatment of bipolar disorder in children and adolescents. Encephale. 2017;43(3):254–258. PubMed CrossRef
  18. Tamayo JM, Zarate CA Jr, Vieta E, et al. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2010;13(6):813–832. PubMed CrossRef
  19. Zimmerman M, Morgan TA. The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neurosci. 2013;15(2):155–169. PubMed CrossRef
  20. Asherson P, Young AH, Eich-Höchli D, et al. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Curr Med Res Opin. 2014;30(8):1657–1672. PubMed CrossRef
  21. Dadomo H, Salvato G, Lapomarda G, et al. Structural features predict sexual trauma and interpersonal problems in borderline personality disorder but not in controls: a multi-voxel pattern analysis. Front Hum Neurosci. 2022;16:773593. PubMed CrossRef
  22. Grecucci A, Lapomarda G, Messina I, et al. Structural features related to affective instability correctly classify patients with borderline personality disorder. a supervised machine learning approach. Front Psychiatry. 2022;13:804440. PubMed CrossRef
  23. Ding JB, Hu K. Structural MRI brain alterations in borderline personality disorder and bipolar disorder. Cureus. 2021;13(7):e16425. PubMed CrossRef
  24. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry. 2003;54(11):1284–1293. PubMed CrossRef
  25. Lapomarda G, Grecucci A, Messina I, et al. Common and different gray and white matter alterations in bipolar and borderline personality disorder: a source-based morphometry study. Brain Res. 2021;1762:147401. PubMed CrossRef
  26. Davies G, Hayward M, Evans S, et al. A systematic review of structural MRI investigations within borderline personality disorder: identification of key psychological variables of interest going forward. Psychiatry Res. 2020;286:112864. PubMed CrossRef
  27. Schulze L, Schmahl C, Niedtfeld I. Neural correlates of disturbed emotion processing in borderline personality disorder: a multimodal meta-analysis. Biol Psychiatry. 2016;79(2):97–106. PubMed CrossRef
  28. Lapomarda G, Pappaianni E, Siugzdaite R, et al. Out of control: an altered parieto-occipital-cerebellar network for impulsivity in bipolar disorder. Behav Brain Res. 2021;406:113228. PubMed CrossRef
  29. Diler RS, Segreti AM, Ladouceur CD, et al. Neural correlates of treatment in adolescents with bipolar depression during response inhibition. J Child Adolesc Psychopharmacol. 2013a;23(3):214–221. PubMed CrossRef
  30. Favre P, Baciu M, Pichat C, et al. Modulation of fronto-limbic activity by the psychoeducation in euthymic bipolar patients: a functional MRI study. Psychiatry Res. 2013;214(3):285–295. PubMed CrossRef
  31. Bertsch K, Gamer M, Schmidt B, et al. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. Am J Psychiatry. 2013;170(10):1169–1177. PubMed CrossRef
  32. Carmona I Farrés C, Elices M, Soler J, et al. Effects of mindfulness training on the default mode network in borderline personality disorder. Clin Psychol Psychother. 2019;26(5):562–571. PubMed CrossRef
  33. Lischke A, Herpertz SC, Berger C, et al. Divergent effects of oxytocin on (para-)limbic reactivity to emotional and neutral scenes in females with and without borderline personality disorder. Soc Cogn Affect Neurosci. 2017;12(11):1783–1792. PubMed CrossRef
  34. Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. PubMed CrossRef
  35. Eickhoff SB, Laird AR, Grefkes C, et al. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp. 2009;30(9):2907–2926. PubMed CrossRef
  36. Laird AR, Eickhoff SB, Fox PM, et al. The BrainMap strategy for standardization, sharing, and meta-analysis of neuroimaging data. BMC Res Notes. 2011;4(1):349. PubMed CrossRef
  37. Lancaster JL, Tordesillas-Gutiérrez D, Martinez M, et al. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp. 2007;28(11):1194–1205. PubMed CrossRef
  38. Eickhoff SB, Nichols TE, Laird AR, et al. Behavior, sensitivity, and power of activation likelihood estimation characterized by massive empirical simulation. Neuroimage. 2016;137:70–85. PubMed CrossRef
  39. Turkeltaub PE, Eickhoff SB, Laird AR, et al. Minimizing within-experiment and within-group effects in activation likelihood estimation meta-analyses. Hum Brain Mapp. 2012;33(1):1–13. PubMed CrossRef
  40. Lancaster JL, Cykowski MD, McKay DR, et al. Anatomical global spatial normalization. Neuroinformatics. 2010;8(3):171–182. PubMed CrossRef
  41. Deckersbach T, Peters AT, Shea C, et al. Memory performance predicts response to psychotherapy for depression in bipolar disorder: a pilot randomized controlled trial with exploratory functional magnetic resonance imaging. J Affect Disord. 2018;229:342–350. PubMed CrossRef
  42. Ives-Deliperi VL, Howells F, Stein DJ, et al. The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: a controlled functional MRI investigation. J Affect Disord. 2013;150(3):1152–1157. PubMed CrossRef
  43. Meusel L-AC, Hall GB, Fougere P, et al. Neural correlates of cognitive remediation in patients with mood disorders. Psychiatry Res. 2013;214(2):142–152. PubMed CrossRef
  44. Venza EE, Chapman SB, Aslan S, et al. Enhancing executive function and neural health in bipolar disorder through reasoning training. Front Psychol. 2016;7:1676–1686. PubMed CrossRef
  45. Diler RS, Ladouceur CD, Segreti A, et al. Neural correlates of treatment response in depressed bipolar adolescents during emotion processing. Brain Imaging Behav. 2013;7(2):227–235. PubMed CrossRef
  46. Garrett AS, Chang KD, Singh MK, et al. Neural changes in youth at high risk for bipolar disorder undergoing family-focused therapy or psychoeducation. Bipolar Disord. 2021;23(6):604–614. PubMed CrossRef
  47. Haldane M, Jogia J, Cobb A, et al. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with lamotrigine monotherapy. Eur Neuropsychopharmacol. 2008;18(1):48–54. PubMed CrossRef
  48. Jogia J, Haldane M, Cobb A, et al. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry. 2008;192(3):197–201. PubMed CrossRef
  49. Marchand WR, Lee JN, Thatcher J, et al. A preliminary longitudinal fMRI study of frontal-subcortical circuits in bipolar disorder using a paced motor activation paradigm. J Affect Disord. 2007;103(1–3):237–241. PubMed CrossRef
  50. Passarotti AM, Sweeney JA, Pavuluri MN. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder. Psychopharmacology (Berl). 2011;216(4):485–499. PubMed CrossRef
  51. Pavuluri MN, Passarotti AM, Fitzgerald JM, et al. Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry. 2012b;51(2):157–170.e5. PubMed CrossRef
  52. Pavuluri MN, Passarotti AM, Lu LH, et al. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes. Psychiatry Res. 2011;193(1):28–37. PubMed CrossRef
  53. Pavuluri MN, Passarotti AM, Parnes SA, et al. A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder. J Child Adolesc Psychopharmacol. 2010;20(5):395–406. PubMed CrossRef
  54. Yang H, Lu LH, Wu M, et al. Time course of recovery showing initial prefrontal cortex changes at 16 weeks, extending to subcortical changes by 3 years in pediatric bipolar disorder. J Affect Disord. 2013;150(2):571–577. PubMed CrossRef
  55. Miskowiak KW, Vinberg M, Glerup L, et al. Neural correlates of improved executive function following erythropoietin treatment in mood disorders. Psychol Med. 2016;46(8):1679–1691. PubMed CrossRef
  56. Miskowiak KW, Petersen NA, Harmer CJ, et al. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder. Acta Psychiatr Scand. 2018;138(4):336–347. PubMed CrossRef
  57. Chang K, DelBello M, Garrett A, et al. Neurofunctional correlates of response to quetiapine in adolescents with bipolar depression. J Child Adolesc Psychopharmacol. 2018;28(6):379–386. PubMed CrossRef
  58. Strakowski SM, Fleck DE, Welge J, et al. fMRI brain activation changes following treatment of a first bipolar manic episode. Bipolar Disord. 2016;18(6):490–501. PubMed CrossRef
  59. Miskowiak KW, Macoveanu J, Vinberg M, et al. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders. Acta Psychiatr Scand. 2016;134(3):249–259. PubMed CrossRef
  60. Dandash O, Yücel M, Daglas R, et al. Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania. Transl Psychiatry. 2018;8(1):59. PubMed CrossRef
  61. Driessen M, Wingenfeld K, Rullkoetter N, et al. One-year functional magnetic resonance imaging follow-up study of neural activation during the recall of unresolved negative life events in borderline personality disorder. Psychol Med. 2009;39(3):507–516. PubMed CrossRef
  62. Niedtfeld I, Schmitt R, Winter D, et al. Pain-mediated affect regulation is reduced after dialectical behavior therapy in borderline personality disorder: a longitudinal fMRI study. Soc Cogn Affect Neurosci. 2017;12(5):739–747. PubMed CrossRef
  63. Paret C, Kluetsch R, Zaehringer J, et al. Alterations of amygdala-prefrontal connectivity with real-time fMRI neurofeedback in BPD patients. Soc Cogn Affect Neurosci. 2016;11(6):952–960. PubMed CrossRef
  64. Perez DL, Vago DR, Pan H, et al. Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder. Psychiatry Clin Neurosci. 2016;70(1):51–61. PubMed CrossRef
  65. Schmitt R, Winter D, Niedtfeld I, et al. Effects of psychotherapy on neuronal correlates of reappraisal in female patients with borderline personality disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1(6):548–557. PubMed CrossRef
  66. Schnell K, Herpertz SC. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res. 2007;41(10):837–847. PubMed CrossRef
  67. Winter D, Niedtfeld I, Schmitt R, et al. Neural correlates of distraction in borderline personality disorder before and after dialectical behavior therapy. Eur Arch Psychiatry Clin Neurosci. 2017;267(1):51–62. PubMed CrossRef
  68. Metz S, Fleischer J, Gärnter M, et al. Effects of hydrocortisone on autobiographical memory retrieval in patients with posttraumatic stress disorder and borderline personality disorder: the role of childhood trauma. Neuropsychopharmacology. 2019;44(12):2038–2044. PubMed CrossRef
  69. Pavuluri MN, Ellis JA, Wegbreit E, et al. Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania. Behav Brain Res. 2012;226(2):493–503. PubMed CrossRef
  70. Zovetti N, Rossetti MG, Perlini C, et al. Default mode network activity in bipolar disorder. Epidemiol Psychiatr Sci. 2020;29:e166. PubMed CrossRef
  71. Visintin E, De Panfilis C, Amore M, et al. Mapping the brain correlates of borderline personality disorder: a functional neuroimaging meta-analysis of resting state studies. J Affect Disord. 2016;204:262–269. PubMed CrossRef
  72. Leech R, Kamourieh S, Beckmann CF, et al. Fractionating the default mode network: distinct contributions of the ventral and dorsal posterior cingulate cortex to cognitive control. J Neurosci. 2011;31(9):3217–3224. PubMed CrossRef
  73. Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015;385(9969):735–743. PubMed CrossRef
  74. Aminoff EM, Kveraga K, Bar M. The role of the parahippocampal cortex in cognition. Trends Cogn Sci. 2013;17(8):379–390. PubMed CrossRef
  75. Ochsner KN, Ray RR, Hughes B, et al. Bottom-up and top-down processes in emotion generation: common and distinct neural mechanisms. Psychol Sci. 2009;20(11):1322–1331. PubMed CrossRef
  76. Malhi GS, Tanious M, Fritz K, et al. Differential engagement of the fronto-limbic network during emotion processing distinguishes bipolar and borderline personality disorder. Mol Psychiatry. 2013;18(12):1247–1248. PubMed CrossRef
  77. Schmahl C, Bremner JD. Neuroimaging in borderline personality disorder. J Psychiatr Res. 2006;40(5):419–427. PubMed CrossRef
  78. Etkin A, Egner T, Peraza DM, et al. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron. 2006;51(6):871–882. PubMed CrossRef
  79. Flasbeck V, Enzi B, Brüne M. Enhanced processing of painful emotions in patients with borderline personality disorder: a functional magnetic resonance imaging study. Front Psychiatry. 2019;10:357. PubMed CrossRef
  80. Carter CS, Braver TS, Barch DM, et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 1998;280(5364):747–749. PubMed CrossRef
  81. Townsend J, Altshuler LL. Emotion processing and regulation in bipolar disorder: a review. Bipolar Disord. 2012;14(4):326–339. PubMed CrossRef
  82. Völlm BA, Taylor AN, Richardson P, et al. Neuronal correlates of theory of mind and empathy: a functional magnetic resonance imaging study in a nonverbal task. Neuroimage. 2006;29(1):90–98. PubMed CrossRef
  83. Fransson P, Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis. Neuroimage. 2008;42(3):1178–1184. PubMed CrossRef
  84. O’Neill A, D’Souza A, Samson AC, et al. Dysregulation between emotion and theory of mind networks in borderline personality disorder. Psychiatry Res. 2015;231(1):25–32. PubMed CrossRef
  85. Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001;50(4):292–298. PubMed CrossRef
  86. Massó Rodriguez A, Hogg B, Gardoki-Souto I, et al. Clinical features, neuropsychology and neuroimaging in bipolar and borderline personality disorder: a systematic review of cross-diagnostic studies. Front Psychiatry. 2021;12:681876. PubMed CrossRef
  87. Wessa M, Linke J. Emotional processing in bipolar disorder: behavioural and neuroimaging findings. Int Rev Psychiatry. 2009;21(4):357–367. PubMed CrossRef
  88. Kupferschmidt DA, Zakzanis KK. Toward a functional neuroanatomical signature of bipolar disorder: quantitative evidence from the neuroimaging literature. Psychiatry Res. 2011;193(2):71–79. PubMed CrossRef
  89. Malhi GS, Lagopoulos J, Sachdev PS, et al. Is a lack of disgust something to fear? a functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. Bipolar Disord. 2007;9(4):345–357. PubMed CrossRef
  90. Kluetsch RC, Schmahl C, Niedtfeld I, et al. Alterations in default mode network connectivity during pain processing in borderline personality disorder. Arch Gen Psychiatry. 2012;69(10):993–1002. PubMed CrossRef
  91. King JB, Anderson JS, Yurgelun-Todd DA, et al. Decreased anterior cingulate activation in a motor task in youths with bipolar disorder. J Child Psychol Psychiatry. 2018;59(8):900–907. PubMed CrossRef
  92. Chen CH, Suckling J, Lennox BR, et al. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord. 2011;13(1):1–15. PubMed CrossRef
  93. Hafeman DM, Bebko G, Bertocci MA, et al. Abnormal deactivation of the inferior frontal gyrus during implicit emotion processing in youth with bipolar disorder: attenuated by medication. J Psychiatr Res. 2014;58:129–136. PubMed CrossRef
  94. Silvers JA, Hubbard AD, Biggs E, et al. Affective lability and difficulties with regulation are differentially associated with amygdala and prefrontal response in women with borderline personality disorder. Psychiatry Res Neuroimaging. 2016;254:74–82. PubMed CrossRef
  95. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13(9):829, 833–857. PubMed
  96. Yatham LN, Torres IJ, Malhi GS, et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord. 2010;12(4):351–363. PubMed CrossRef
  97. Ridderinkhof KR, Ullsperger M, Crone EA, et al. The role of the medial frontal cortex in cognitive control. Science. 2004;306(5695):443–447. PubMed CrossRef
  98. Welander-Vatn A, Jensen J, Otnaess MK, et al. The neural correlates of cognitive control in bipolar I disorder: an fMRI study of medial frontal cortex activation during a Go/No-go task. Neurosci Lett. 2013;549:51–56. PubMed CrossRef
  99. Sripada CS, Silk KR. The role of functional neuroimaging in exploring the overlap between borderline personality disorder and bipolar disorder. Curr Psychiatry Rep. 2007;9(1):40–45. PubMed CrossRef
  100. Laidi C, Houenou J. Brain functional effects of psychopharmacological treatments in bipolar disorder. Eur Neuropsychopharmacol. 2016;26(11):1695–1740. PubMed CrossRef
  101. Zhang L, Li W, Wang L, et al. Altered functional connectivity of right inferior frontal gyrus subregions in bipolar disorder: a resting state fMRI study. J Affect Disord. 2020;272:58–65. PubMed CrossRef
  102. McGrath CL, Kelley ME, Holtzheimer PE, et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry. 2013;70(8):821–829. PubMed CrossRef
  103. Mel’nikov ME, Petrovskii ED, Bezmaternykh DD, et al. fMRI response of parietal brain areas to sad facial stimuli in mild depression. Bull Exp Biol Med. 2018;165(6):741–745. PubMed CrossRef
  104. Quidé Y, Witteveen AB, El-Hage W, et al. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci Biobehav Rev. 2012;36(1):626–644. PubMed CrossRef
  105. Petersen TJ. Enhancing the efficacy of antidepressants with psychotherapy. J Psychopharmacol. 2006;20(suppl):19–28. PubMed CrossRef
Buy PDF for $40

Please sign in or purchase this PDF for $40.

Save Save

Cite Cite

Vol 86 • 2025 • Number 1

Read the Current Issue

Original Research

Psychological Support in Psychedelic Therapy

Original Research

Long-Term Safety and Efficacy of Esmethadone in MDD

Original Research

Suicidal Behaviors and Obstructive Sleep Apnea

Editorial

A Collaborative Endeavor

Brief Report

Sex Differences in PTSD among US Military Veterans

Clinical and Practical Psychopharmacology

Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes in Children and Young Adults
View current Issue

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe